Evidence map›Paper›PMID 35650276›Full record

ReviewBritish journal of cancer2022

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Emily Latacz, Diederik Höppener, Ali Bohlok, Sophia Leduc, Sébastien Tabariès, Carlos Fernández Moro, Claire Lugassy, Hanna Nyström, Béla Bozóky, Giuseppe Floris and 34 more

2 registry-linked trialsAbstract readReview
In one paragraph

Review in British journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06208397 recruitingnot on this mapstarted 2023, after this paper: background citation

Noninvasive Evaluation in Diagnosis and Treatment of Histopathological Growth Patterns in Colorectal Liver Metastases Using MR Elastography-based Shear Strain Mapping

TypeobservationalSponsorShengjing HospitalRan2023 to 2026Enrolled50ConditionsMetastatic Colorectal CancerArmsMagnetic Resonance Elastography and routine MRI
NCT07564908 active not recruitingnot on this map

Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases

TypeobservationalSponsorMeng QiuRan2018 to 2030Enrolled64ConditionsColorectal NeoplasmsArmsFormalin-fixed, paraffin-embedded (FFPE) sections of colorectal cancer liver metastases were stained with hematoxylin and eosin (H&E) and Multiplex immunohistochemistry (mIHC) staining.
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Liver metastases beyond classical imaging findings.Abdominal radiology (New York) · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors.

Emily Latacz *Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium.
Diederik Höppener *Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Ali Bohlok *Department of Surgical Oncology, Institut Jules Bordet, Brussels, Belgium.ORCID http://orcid.org/0000-0002-9020-4191
Sophia LeducLaboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Sébastien TabarièsDepartment of Medicine, Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0003-3513-6111
Carlos Fernández MoroDepartment of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Huddinge, Sweden.
Claire LugassyDepartment of Translational Research, Institut Curie, Paris, France.ORCID http://orcid.org/0000-0003-4390-4360
Hanna NyströmDepartment of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden.
Béla BozókyDepartment of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Huddinge, Sweden.
Giuseppe FlorisDepartment of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2391-5425
Natalie GeyerDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Pnina BrodtDepartment of Surgery, Oncology and Medicine, McGill University and the Research Institute, McGill University Health Center, Montreal, QC, Canada.
Laura LladoHBP and Liver Transplantation Unit, Department of Surgery, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
Laura Van MileghemTranslational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium.
Maxim De SchepperLaboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Ali W MajeedSheffield Teaching Hospitals NHS Trust, Sheffield, UK.
Anthoula LazarisCancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-2173-7891
Piet DirixTranslational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium.
Qianni ZhangSchool of Electronic Engineering and Computer Science, Queen Mary University of London, London, UK.
Stéphanie K PetrilloCancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Sophie VankerckhoveDepartment of Surgical Oncology, Institut Jules Bordet, Brussels, Belgium.
Ines JoyeTranslational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium.
Yannick MeyerDepartment of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Alexander GregorieffCancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Nuria Ruiz RoigDepartment of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
Fernando Vidal-VanaclochaGWU-Cancer Center, Department of Biochemistry and Molecular Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC, USA.
Larsimont DenisDepartment of Pathology, Institut Jules Bordet, Brussels, Belgium.ORCID http://orcid.org/0000-0003-2152-253X
Rui Caetano OliveiraPathology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Peter MetrakosCancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Dirk J GrünhagenDepartment of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-8293-6002
Iris D NagtegaalDepartment of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.ORCID http://orcid.org/0000-0003-0887-4127
David G MolleviTumoral and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.
William R JarnaginDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Michael I D'AngelicaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrew R ReynoldsOncology R&D, AstraZeneca, Cambridge, UK.
Michail DoukasDepartment of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
Christine DesmedtLaboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5223-5579
Luc DirixTranslational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium.
Vincent Donckier *Department of Surgical Oncology, Institut Jules Bordet, Brussels, Belgium.
Peter M Siegel *Department of Medicine, Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC, Canada.
Raymond Barnhill *Department of Translational Research, Institut Curie, Paris, France.
Marco Gerling *Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Cornelis Verhoef *Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Peter B Vermeulen *Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium. peter.vermeulen@gza.be.ORCID http://orcid.org/0000-0002-5676-3141

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)U01CA238444 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CERCEK, ANDREA, IACOBUZIO-DONAHUE, CHRISTINE A · 2020 to 2024
$3.3M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The first consensus guidelines for scoring the histopathological growth patterns (HGPs) of liver metastases were established in 2017. Since then, numerous studies have applied these guidelines, have further substantiated the potential clinical value of the HGPs in patients with liver metastases from various tumour types and are starting to shed light on the biology of the distinct HGPs. In the present guidelines, we give an overview of these studies, discuss novel strategies for predicting the HGPs of liver metastases, such as deep-learning algorithms for whole-slide histopathology images and medical imaging, and highlight liver metastasis animal models that exhibit features of the different HGPs. Based on a pooled analysis of large cohorts of patients with liver-metastatic colorectal cancer, we propose a new cut-off to categorise patients according to the HGPs. An up-to-date standard method for HGP assessment within liver metastases is also presented with the aim of incorporating HGPs into the decision-making processes surrounding the treatment of patients with liver-metastatic cancer. Finally, we propose hypotheses on the cellular and molecular mechanisms that drive the biology of the different HGPs, opening some exciting preclinical and clinical research perspectives.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsAnimals

Identifiers

PMID35650276
PMCPMC9470557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.